Categories: News

Sandstone Easydrip Plus Pen Needles Debut in Turkey — PatentProtected Hexagonal Hub for Comfort and Control

Large‑platform hexagonal hub (Hextra Tech) offers superior stability and ease of grip; ISO 13485 & CE certified; launched by a leading regional diabetes distributor and 4,000+ pharmacies

- Advertisement -

ISTANBUL, Oct. 11, 2025 /PRNewswire/ — Sandstone Medical — a SteriLance Medical sub‑brand focused on diabetes self‑injection — today announced the introduction of its Easydrip™ Plus pen needles into the Turkish market through a leading regional diabetes distributor with a nationwide pharmacy network. The launch is already unlocking interest from neighbouring Middle‑East markets.

- Advertisement -

Key advantages

- Advertisement -
  • Hextra Tech hexagonal hub — a broad, six‑facet platform that helps patients keep the pen steady during insertion, reducing wobble, bruising and needle bending versus conventional narrow‑hub pen needles.
  • Greater dosing confidence — the enlarged contact surface promotes a consistent injection angle, supporting accurate sub‑cutaneous delivery.
  • Thin‑wall cannula with silicone lubrication — minimises penetration force and shortens injection time for a gentler daily routine.

Market relevance

- Advertisement -

As the first pen needle with a patent‑protected hexagonal hub available in Turkey, Easydrip™ Plus is already attracting interest from neighbouring countries and sets a practical alternative between premium global brands and low‑end generics.

- Advertisement -

Availability & next steps

- Advertisement -
  • Current channel: nationwide community pharmacies, often bundled with blood‑glucose meters.
  • Planned expansion: influencer‑driven digital campaigns and e‑commerce to reach online‑first consumers across Turkey and neighbouring states.

Certifications

- Advertisement -

Easydrip™ Plus is manufactured under a strict ISO 13485 quality system and holds CE Declaration of Conformity, meeting international safety and performance standards.

- Advertisement -

Brand Relationship

- Advertisement -

Sandstone Medical is SteriLance Medical’s diabetes‑care brand focused on self‑injection. Easydrip™ products are developed and marketed by Sandstone, with SteriLance providing manufacturing and quality systems under ISO 13485.

- Advertisement -

About Sandstone and SteriLance Medical

- Advertisement -

Sandstone designs patient‑centric solutions that make daily injections steadier and more comfortable. Founded in 1993, SteriLance Medical is a global innovator in blood‑sampling and injection solutions with 200+ patents and distribution in 50+ countries.
More information: en.sandstonemed.com | en.sterilance.com 
Media & distribution enquiries: smu@sterilance.com 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2794048/Bridging_gap_premium_low_end_options__advanced_large_platform_design__ISO_13485.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/sandstone-easydrip-plus-pen-needles-debut-in-turkey–patentprotected-hexagonal-hub-for-comfort-and-control-302581334.html

- Advertisement -

Recent Posts

Charles Winslow Completes Annual Internal Strategic Review at Lumena Intelligent Alliance Office

Jersey City, NJ, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Lumena Intelligent Alliance Office confirmed that…

4 hours ago

DebitMyData Human Energy Grid: The Trillion-Dollar Infrastructure Play That Genesis Executive Order Validates

DebitMyData™ Logo FORT LAUDERDALE, Fla., Dec. 25, 2025 (GLOBE NEWSWIRE) -- DebitMyData, Inc., having oversubscribed…

4 hours ago

Yoolax Announces a Milestone 2025 of Growth, Smart Innovation, and Customer Trust

HongKong, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Yoolax, a leading brand in the motorized window…

4 hours ago

Profound Medical Corp. Announces Upsize of Private Placement

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the…

7 hours ago

ImmuCell Announces Strategic Focus on First Defense After Receiving an FDA Incomplete Letter for Re-Tain

December 24, 2025 13:05 ET  | Source: ImmuCell Corporation PORTLAND, Maine, Dec. 24, 2025 (GLOBE…

7 hours ago

WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025

Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK)…

7 hours ago